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ABSTRACT 
 
Background: lateral epicondylar tendinopathy also known as tennis elbow is a common condition and one of the 
most common overuse syndrome. platelet rich plasma is reservoir of growth factor’s  and set of molecules which 
accelerate healing process and regenerate tissue. Material and method: During august 2014 to April 2016, 120 
patients of tennis elbow who failed conservative treatment were treated with   Autologus platelet rich plasma 
injection and results were evaluated with VAS and DASH score. All patients were followed up to 24 weeks, at 2 
week interval. Results: among 120 patients with tennis elbow (72 males and 48 females) significant difference were 
observed in  VAS and DASH score at baseline and after 4 weeks, 8 weeks and 12 weeks post injection (p<0.001).  
No complication observed. Conclusion: Autologus platelet rich plasma injection is a safe and effective treatment in 
refractory case of lateral epicondylitis . 
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Introduction 
 
 
Lateral epicondylitis or tennis elbow result from 
overuse of extensor muscle of forearm leading to 
damage of affected tendon and present with pain and 
tenderness in the region of common extensor tendon 
insertion on lateral epicondyle of humerus (lateral side 
of elbow). Tendon repair is very slow due to relatively 
low blood supply. Epicondylitis is misnomer because 
of low level of inflammatory cell at tendon site but 
rather excess of fibroblasts and blood vessels consistent 
with finding of neo angiogenesis.[1] platelet rich 
plasma is an ideal autologus biological product which 
release high concentration of platelet derived growth 
factor that enhance tendon healing.[2]  platelet are 
activated by thrombin and collagen releasing growth 
factor that attract undifferentiated cells into newly 
formed matrix and trigger cell division [3].   
_______________________________ 
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platelet rich plasma can inhibit cytokine release from 
macrophage accelerate tissue healing and 
regeneration.[4]  We studied effect of Autologus  
platelet rich plasma injection in refractory case of 
tennis elbow who failed to respond to conservative 
treatment of 12 weeks. 
 
Material and method  
 
The study has been approved by ethical committee of 
our institution. During august 2014 to April 2016, 120 
refractory case of tennis elbow who failed to respond 
after 12 weeks of conservative treatment were treated 
with   Autologus platelet rich plasma injection in 
department of orthopedics J.L.N. medical collage 
Ajmer.  Out of 120, 72 were males and 48 were 
females. NSAID were stopped one week before and 
avoided in follow up. 
Inclusion criteria- 
- Tenderness over lateral aspect of elbow  
- Positive cozen test, wringing test, mills maneuver and 
jar lifting test. 
Exclusion criteria- 
 -pregnancy    
 -anemia   ( Hb <7) 
 -thrombocytopenia (platelet<150*10 3)  
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 -any malignancy 
 -history of local corticosteroid injection 
  -diabetes mellitus 
  -rheumatoid arthritis  
  -Patients on anticoagulant therapy 
Method for data collection  
 Data collected by verbal communication with patients 
including inform consent. Written documentation 
(VAS) and evaluation of limitation of function (DASH) 
was done before and at each follow up. Complete 
blood count, bleeding time, clotting time, blood sugar 
was done before procedure. 
 Platelet rich plasma preparation 
 Draw34 ml of venous blood using 50ml disposable 
syringe and pour into four 8.5ml ACD-A containing 
vacuum sterile glass tube and centrifuge for 2500rmp 
for 7 min at 22degree Celsius in centrifuge machine 
(PRP centrifuge, Model –CM-8 plus, REMI company, 
WHO guidelines, with ISO9001/2008 certification) 
resulting in the three following layers: the inferior layer 
contain erythrocyte, the intermediate layer contain 
leukocyte and the superior layer made of plasma. The 
Buffy coat layer together with plasma layer was 
transferred in to another sterile tube( without 
anticoagulant ) by using separate 20cc disposal syringe 
and centrifuge for 3000 rpm for 6 min. the lower 1/3rd 
is platelet rich plasma and upper 2/3rd platelet poor 
plasma is obtained after 2nd centrifugation.  Using 
20cc disposal syringe remove platelet poor plasma. 
Remaining is platelet rich plasma gently shacked to 
suspend platelets in PRP and gently aspirated and used 
for injection in tennis elbow within 30 min of 
preparation. An aliquot of product was sent to the 
laboratory for analysis of platelet concentration. 
Procedure  
 The patient is supine under strict aseptic precaution 
2% xylocaine followed by PRP injection into the 
affected site with a 18-guage needle and advised to 
take rest for 15min. limb is immobilized in elastic 
crepe bandage and cuff and collar for 48 hr and advised 
to avoid activity that involve wrist extension. After  48 
hr patients allowed to do daily activity.   
 
Observation and results 
 
The mean age of patients in our study was 37.5 
±15.5year and includes 72 males and 48females. 
Follow up every 2weeks and VAS and DASH score 
recorded. Below table compare the mean VAS and 
DASH score during first visits and at 4th week, 8th 
week and 12th week. 
                                                                       
Table 1: Mean VAS and DASH score during first visits and at 4th week, 8th week and 12th week 
 
score 1st visit Post PRP injection 
At 4th wk P At 8th wk P At 12th wk P 
VAS 8.2±0.76 3.9±1.2 <0.0036 3±1.2 <0.001 2.7±1.2 <0.001 
DASH 74±6.7 37±9.3 <0.0018 34±6.5 <0.001 31.2±9.4 <0.001 
 
In our study we observed highly significant difference between VAS and DASH score before and after PRP 
injection P<0.001 after 4th to 8th week of injection.80% patient has excellent VAS score improvement (>50% 
reduction) and 60% had excellent DASH score reduction (>50% reduction).No significant complication observed in 
any case other then edema and inflammation at local injection site in 16 cases which resolved with ICING and 
NSAID. 
 
Discussion  
 
PRP use in orthopaedics is new field of study, PRP are 
used now a days for various tendinopathy, shoulder 
impingement, osteoarthritis,  avascular necrosis and 
planter fasciitis . Autologus PRP improve early 
neotendens properties[5] and improvement of tissue 
healing by enhancing cellular chemo taxis, 
proliferation and differentiation of cells, angiogenesis 
and laying of extra cellular matrix.[6]Our observation 
are similar to those describe by mishra and pavelko[7] 
who reported a significant improvement of symptom in 
patients of tennis elbow after PRP injection ,60% of 
improved at the end of 8th week in there VAS score 
(P<0.001). Our observation also similar to Peerboom et 
al[8] who reported that 49% patients in corticosteroid 
injection group and 73% patients in PRP group was 
successful  (P<0.001).PRP injection  have been 
compare to several other treatment modalities.  
Available literature suggest that PRP may be more 
effective then needling[9], laser therapy[10,11]  and 
local anesthetic  injection.[12] One trial found that PRP 
was no better than saline injection.[13] However 
prepared PRP in this study was estimated to have 1.6 
time concentration which is below 4-5 times 
concentration of platelets need to provide optimal 
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results.Adverse effect are rare with PRP other then 
local edema and inflammation in some case. 
Conversely corticosteroid tend to have short relief but 
associated with long term degenerative effect on 
tendon integrity.[9,14,15]Most of clinical trial 
demonstrated a significant benefit of PRP over 
corticosteroid injection for pain related end 
point.[10,11,13,16-18] 
 
Conclusion 
 
Autologous PRP injection is safe and effective 
treatment for refractory case of tennis elbow. It relieves 
pain and improve function in most of the case and 
available literature also support the use of PRP in 
tennis elbow. 
 
 
Fig 1:Various laboratory reports of PRP prepared in the study showing higher concentration of platelet 
achieved 
 
 
 
Fig 2: PRP preparation using centrifuge machine 
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Fig3: 3 layer formation (from top to bottom :Plasma,buffy coat,RBC precipitate) 
 
 
 
Fig 4: Prepared platelet rich plasma 
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Fig 5: Graph showing improvement in visual analog scale 
 
 
Fig 6: Graph showing improvement in disabilities of Arm Shoulder and Hand Score 
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